Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 9122 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#9122, RRID:AB_823567
- Product name
- MEK1/2 Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat, Drosophila, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references Ankrd26 gene disruption enhances adipogenesis of mouse embryonic fibroblasts.
1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.
Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells.
Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene.
CD45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate 13-acetate-dependent activation and tyrosine phosphorylation of protein kinase Cdelta.
Nuclear shuttling of mitogen-activated protein (MAP) kinase (extracellular signal-regulated kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells.
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.
Fei Z, Bera TK, Liu X, Xiang L, Pastan I
The Journal of biological chemistry 2011 Aug 5;286(31):27761-8
The Journal of biological chemistry 2011 Aug 5;286(31):27761-8
1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.
Thompson T, Andreeff M, Studzinski GP, Vassilev LT
Molecular cancer therapeutics 2010 May;9(5):1158-68
Molecular cancer therapeutics 2010 May;9(5):1158-68
Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells.
Piatelli MJ, Wardle C, Blois J, Doughty C, Schram BR, Rothstein TL, Chiles TC
Journal of immunology (Baltimore, Md. : 1950) 2004 Mar 1;172(5):2753-62
Journal of immunology (Baltimore, Md. : 1950) 2004 Mar 1;172(5):2753-62
Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene.
Umenishi F, Schrier RW
The Journal of biological chemistry 2003 May 2;278(18):15765-70
The Journal of biological chemistry 2003 May 2;278(18):15765-70
CD45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate 13-acetate-dependent activation and tyrosine phosphorylation of protein kinase Cdelta.
Deszo EL, Brake DK, Cengel KA, Kelley KW, Freund GG
The Journal of biological chemistry 2001 Mar 30;276(13):10212-7
The Journal of biological chemistry 2001 Mar 30;276(13):10212-7
Nuclear shuttling of mitogen-activated protein (MAP) kinase (extracellular signal-regulated kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells.
Furuno T, Hirashima N, Onizawa S, Sagiya N, Nakanishi M
Journal of immunology (Baltimore, Md. : 1950) 2001 Apr 1;166(7):4416-21
Journal of immunology (Baltimore, Md. : 1950) 2001 Apr 1;166(7):4416-21
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.
Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD
The EMBO journal 2000 Dec 1;19(23):6341-50
The EMBO journal 2000 Dec 1;19(23):6341-50
No comments: Submit comment
No validations: Submit validation data